Co-Diagnostics Inc. (CODX)
Symbol Info
Listed Symbol CODX
Name Co-Diagnostics Inc.
Share Info
Annual Info
Latest Fiscal Dividend Per Share $-
Latest Fiscal Date 2018-12-31
Latest Fiscal Revenue $39,911
Latest Fiscal EPS $-0.50
Price Info
21 Day Moving Average $1.0769
21 Day EMA $1.076100
50 Day Moving Average $1.1222
50 Day EMA $1.083680
200 Day EMA $1.313540
200 Day Moving Average 1.083950
52 Week High $3.77
52 Week Low $0.69
52 Week Change $-56.818200
Alpha -0.032814
Beta 1.4659
Standard Deviation 0.248099
R2 0.054630
Periods 27
Share Information
10 Day Average Volume 82,979
20 Day Average Volume 71,349
30 Day Average Volume 106,086
50 Day Average Volume 129,987
Outstanding Shares 17,118,766
Float Shares 14,843,766
Percent Float 86.71%
Short Interest -
Short Percent Float -
Short Interest Ratio -
Short Date
Holders
Institutions 20
Institute Holdings Date 2019-09-30
Institute Bought Previous 3 Months 299,804
Institute Holdings Percent 11.300000
Institute Sold Previous 3 Months 652,530
Insider Holdings Date 2019-08-31
Insider Bought Previous 3 Months -
Insider Holdings Percent 13.30%
Insider Sold Previous 3 Months -
Insiders Shares Owned 2,275,000
Price Change
7 Day Price Change $-0.0750001
7 Day Percent Change -6.70%
21 Day Price Change $-0.015
21 Day Percent Change -1.42%
30 Day Price Change $-0.0216
30 Day Percent Change -2.03%
Month To Date Price Change $0.0150
Month To Date Percent 1.46%
90 Day Price Change $-0.04
90 Day Percent Change -3.69%
Quarter To Date $0.015000
Quarter To Date Percent 1.46%
180 Day Price Change $-0.0272
180 Day Percent Change -2.54%
200 Day Price Change $-0.145
200 Day Percent Change -12.18%
Year To Date $-0.445
Year To Date Percent -29.87%
Profile
Description Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV. The company's diagnostics systems enable very rapid, low-cost, sophisticated molecular testing for organisms and genetic diseases by greatly automating historically complex procedures in both the development and administration of tests.
Details
Issue Type CS
Market Cap $17,889,110
Sec Type EQS
Auditor Haynie & Company
Total Shares Outstanding 17,118,766
CEO Dwight H Egan
Employees 22
Last Audit UQ
Classification
CIK 0001692415
Industry Medical Diagnostics & Research
Sector Healthcare
NAICS Surgical and Medical Instrument Manufacturing(339112)
Info
Address 2401 South Foothill Drive
Salt Lake City, UT 84109
Website http://www.codiagnostics.com
Facisimile
Telephone +1 801 438-1036
Email
Key Ratios
Profitability
EBIT Margin -7,089.1
EBITDA Margin -7,024.2
Pre-Tax Profit Margin -
Profit Margin Cont -
Gross Margin 43.10
Profit Margin TOT -
Income Statements
Revenue $75,797
Revenue Per Share $0.0044
Revenue 3 Years $-
Revenue 5 Years $-
Valuation Measures
PE Ratio -
Enterprise Value $13,776,347
Price To Sales 236.013440
Price To Free Cash -4.1
PE High Last 5 Years -
Price To Book 3.6
Price To Cash Flow -
PE Low Last 5 Years -
Price To Tangible Book 3.6
Financial Strength
Total Debt To Equity -
Int Coverage -25.1
Current Ratio 14.6
Leverage Ratio 1.1
Quick Ratio 12.6
Long Term Debt To Capital -
Assets
Receivables Turnover 1.3
Invoice Turnover 11.80
Assets Turnover -
Management Effectiveness
Return Assets -172.96
Return On Equity -208.37
Return On Capital -201.25
Dividends
Dividend 3 Years $-
Dividend 5 Years $-
Ex Dividend Date
Dividend Rate $-
Dividend Yield -
Payment Type
Your Recent History
NASDAQ
CODX
Co Diagnos..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20191015 19:17:32